BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31035809)

  • 1. Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listeners.
    Smith CH; Patel S; Woolley RL; Brady MC; Rick CE; Halfpenny R; Rontiris A; Knox-Smith L; Dowling F; Clarke CE; Au P; Ives N; Wheatley K; Sackley CM
    Clin Linguist Phon; 2019; 33(10-11):1063-1070. PubMed ID: 31035809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intelligibility of dysarthric speech: perceptions of speakers and listeners.
    Walshe M; Miller N; Leahy M; Murray A
    Int J Lang Commun Disord; 2008; 43(6):633-48. PubMed ID: 18608608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of visual information on the intelligibility of dysarthric speech.
    Keintz CK; Bunton K; Hoit JD
    Am J Speech Lang Pathol; 2007 Aug; 16(3):222-34. PubMed ID: 17666548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A serious game for speech training in dysarthric speakers with Parkinson's disease: Exploring therapeutic efficacy and patient satisfaction.
    Ganzeboom M; Bakker M; Beijer L; Strik H; Rietveld T
    Int J Lang Commun Disord; 2022 Jul; 57(4):808-821. PubMed ID: 35338751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of speaking task on intelligibility in Parkinson's disease.
    Tjaden K; Wilding G
    Clin Linguist Phon; 2011 Feb; 25(2):155-68. PubMed ID: 20887216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Picture Description in the Assessment of Connected Speech Intelligibility in Parkinson's Disease: A Pilot Study.
    Johansson IL; Samuelsson C; Müller N
    Folia Phoniatr Logop; 2022; 74(5):320-334. PubMed ID: 35021169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perception of coarticulatory information in normal speech and dysarthria.
    Tjaden K; Sussman J
    J Speech Lang Hear Res; 2006 Aug; 49(4):888-902. PubMed ID: 16908883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internally Versus Externally Cued Speech in Parkinson's Disease and Cerebellar Disease.
    Weir-Mayta P; Spencer KA; Eadie TL; Yorkston K; Savaglio S; Woollcott C
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):583-595. PubMed ID: 28654941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speech intelligibility of Parkinson's disease patients evaluated by different groups of healthcare professionals and naïve listeners.
    Carvalho J; Cardoso R; Guimarães I; Ferreira JJ
    Logoped Phoniatr Vocol; 2021 Oct; 46(3):141-147. PubMed ID: 32633172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speech rate effects upon intelligibility and acceptability of dysarthric speech.
    Dagenais PA; Brown GR; Moore RE
    Clin Linguist Phon; 2006; 20(2-3):141-8. PubMed ID: 16428230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship Between F2 Slope and Intelligibility in Parkinson's Disease: Lexical Effects and Listening Environment.
    Chiu YF; Forrest K; Loux T
    Am J Speech Lang Pathol; 2019 Jul; 28(2S):887-894. PubMed ID: 31306601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybridizing conversational and clear speech to investigate the source of increased intelligibility in speakers with Parkinson's disease.
    Tjaden K; Kain A; Lam J
    J Speech Lang Hear Res; 2014 Aug; 57(4):1191-205. PubMed ID: 24686409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speech and communication in Parkinson's disease: a cross-sectional exploratory study in the UK.
    Barnish MS; Horton SMC; Butterfint ZR; Clark AB; Atkinson RA; Deane KHO
    BMJ Open; 2017 May; 7(5):e014642. PubMed ID: 28554918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intelligibility in Down syndrome: Effect of measurement method and listener experience.
    O'Leary D; Lee A; O'Toole C; Gibbon F
    Int J Lang Commun Disord; 2021 May; 56(3):501-511. PubMed ID: 33783924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear Speech Variants: An Investigation of Intelligibility and Speaker Effort in Speakers With Parkinson's Disease.
    Stipancic KL; van Brenk F; Kain A; Wilding G; Tjaden K
    Am J Speech Lang Pathol; 2022 Nov; 31(6):2789-2805. PubMed ID: 36327495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of speaker and listener variables on intelligibility of dysarthric speech.
    Patel R; Usher N; Kember H; Russell S; Laures-Gore J
    J Commun Disord; 2014; 51():13-8. PubMed ID: 25113966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of speech task on intelligibility in dysarthria: a case study of Parkinson's disease.
    Kempler D; Van Lancker D
    Brain Lang; 2002 Mar; 80(3):449-64. PubMed ID: 11896652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis.
    Tjaden K; Sussman JE; Wilding GE
    J Speech Lang Hear Res; 2014 Jun; 57(3):779-92. PubMed ID: 24687042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.